Milei’s “Golden Moment” Is Making History
Log In Enter your username and password below USERNAME OR EMAIL PASSWORD Forgot Password?Register Remember...
Read MorePosted by Andy Linnell | Aug 28, 2025
Log In Enter your username and password below USERNAME OR EMAIL PASSWORD Forgot Password?Register Remember...
Read MorePosted by Andy Linnell | Aug 21, 2025
Our aim here at 10X Stocks is a lofty one … Very few stocks ever reach a 1,000% return, let alone in a small handful of years. This month, we passed the three-year mark for one of our top-performing positions, Hims & Hers Health (HIMS).
Read MorePosted by Andy Linnell | Aug 14, 2025
Our mission here at 10X Stocks has always been to position ourselves for the biggest possible gains the equity market has to offer… That’s ultimately the core strength of our strategy here: We’re targeting those massive gains through equity investing — not through derivatives, cryptocurrencies, or any of the other means often used to maximize profits, which can of course have meaningful drawbacks.
Read MorePosted by Andy Linnell | Aug 7, 2025
Congratulations! If you followed my optional trade recommendation from last week, then you’ve already pocketed a quick and easy $310 (per contract) on one of our top-performing 10X Stocks — Hims & Hers Health (HIMS). As I explained last week, I fully expect HIMS to continue climbing over the next few years, but the potential for near-term volatility justifies taking some of our chips off the table.
Read MorePosted by Andy Linnell | Jul 24, 2025
Hello, and welcome back to 10X Stocks! As I write, we’ve got not one but two different stocks charging past 700% gains on the way to becoming our first true 10X position. Of course, I’m speaking about nuclear power innovator Nuscale Power (SMR) and our play in the health care space, Hims & Hers Health (HIMS), which are currently up 786% and 722%, respectively.
Read MoreIn his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below